-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Acquired by First Republic Investment Management Inc.
Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Acquired by First Republic Investment Management Inc.
First Republic Investment Management Inc. lifted its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) by 8.5% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,408 shares of the medical research company's stock after buying an additional 188 shares during the period. First Republic Investment Management Inc.'s holdings in Bio-Rad Laboratories were worth $1,004,000 at the end of the most recent quarter.
Other hedge funds have also made changes to their positions in the company. SeaCrest Wealth Management LLC acquired a new stake in shares of Bio-Rad Laboratories during the second quarter worth about $26,000. Private Trust Co. NA boosted its stake in shares of Bio-Rad Laboratories by 230.0% during the third quarter. Private Trust Co. NA now owns 66 shares of the medical research company's stock worth $28,000 after buying an additional 46 shares during the period. Atlas Capital Advisors LLC acquired a new stake in shares of Bio-Rad Laboratories during the second quarter worth about $50,000. Allworth Financial LP boosted its stake in shares of Bio-Rad Laboratories by 414.8% during the third quarter. Allworth Financial LP now owns 139 shares of the medical research company's stock worth $58,000 after buying an additional 112 shares during the period. Finally, Sentry Investment Management LLC boosted its stake in shares of Bio-Rad Laboratories by 16.5% during the second quarter. Sentry Investment Management LLC now owns 148 shares of the medical research company's stock worth $73,000 after buying an additional 21 shares during the period. Institutional investors and hedge funds own 64.35% of the company's stock.
Get Bio-Rad Laboratories alerts:Bio-Rad Laboratories Price Performance
BIO stock opened at $470.88 on Friday. The firm has a 50 day moving average of $432.84 and a 200-day moving average of $447.37. Bio-Rad Laboratories, Inc. has a 12-month low of $344.63 and a 12-month high of $670.61. The company has a current ratio of 5.50, a quick ratio of 4.30 and a debt-to-equity ratio of 0.14. The company has a market cap of $14.04 billion, a price-to-earnings ratio of -2.33 and a beta of 0.92.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently commented on the stock. TheStreet downgraded shares of Bio-Rad Laboratories from a "c" rating to a "d+" rating in a research report on Thursday, October 27th. Credit Suisse Group reduced their price objective on shares of Bio-Rad Laboratories from $715.00 to $640.00 and set an "outperform" rating for the company in a research report on Friday, October 28th. StockNews.com downgraded shares of Bio-Rad Laboratories from a "buy" rating to a "hold" rating in a research report on Wednesday, January 18th. Finally, Royal Bank of Canada assumed coverage on shares of Bio-Rad Laboratories in a research report on Tuesday, December 6th. They issued an "outperform" rating and a $565.00 price objective for the company. One analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat, Bio-Rad Laboratories presently has a consensus rating of "Moderate Buy" and a consensus price target of $651.25.Bio-Rad Laboratories Company Profile
(Get Rating)
Bio-Rad Laboratories, Inc engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Sciences and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments.
Read More
- Get a free copy of the StockNews.com research report on Bio-Rad Laboratories (BIO)
- Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
- Zimmer Biomet Beats on Earnings, Growth May be Priced In
- AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
- Ford Stock Going Forward After Big Earnings Flop
- Insiders And Institutions Buy Wolverine Worldwide
Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
第一共和投資管理公司(First Republic Investment Management Inc.)根據其最近提交給美國證券交易委員會的Form 13F檔案,在第三季度增持了Bio-Rad實驗室公司的股票8.5%。該公司持有這家醫學研究公司2,408股股票,在此期間又購買了188股。截至最近一個季度末,First Republic Investment Management Inc.持有的Bio-Rad實驗室股份價值1,004,000美元。
其他對沖基金也對他們在該公司的頭寸進行了調整。Seacrest Wealth Management LLC在第二季度收購了Bio-Rad實驗室價值約2.6萬美元的新股。私人信託公司NA在第三季度將其在Bio-Rad實驗室的持股增加了230.0%。私人信託公司NA現在擁有66股這家醫療研究公司的股票,價值28,000美元,在此期間又購買了46股。Atlas Capital Advisors LLC在第二季度收購了Bio-Rad實驗室價值約5萬美元的新股。Allworth Financial LP在第三季度將其在Bio-Rad實驗室的股份增加了414.8%。Allworth Financial LP現在擁有139股這家醫療研究公司的股票,價值5.8萬美元,在此期間又購買了112股。最後,Sentry Investment Management LLC在第二季度將其在Bio-Rad實驗室的持股增加了16.5%。在此期間,哨兵投資管理公司又購買了21股,現在擁有148股這家醫療研究公司的股票,價值73,000美元。機構投資者和對沖基金持有該公司64.35%的股票。
到達Bio-Rad實驗室警報:Bio-Rad實驗室性價比
週五,Bio股價開盤報470.88美元。該公司的50日移動均線切入位在432.84美元,200日移動均線切入位在447.37美元。Bio-Rad實驗室,Inc.的12個月低點為344.63美元,12個月高位為670.61美元。該公司的流動比率為5.50,速動比率為4.30,債務權益比率為0.14。該公司市值為140.4億美元,本益比為-2.33倍,貝塔係數為0.92。
華爾街分析師預測經濟增長
一些股票研究分析師最近對該股發表了評論。華爾街在10月27日星期四的一份研究報告中將Bio-Rad實驗室的股票評級從“c”下調至“d+”。瑞士信貸集團將Bio-Rad實驗室股票的目標價從715.00美元下調至640.00美元,並在10月28日星期五的一份研究報告中為該公司設定了“跑贏大盤”的評級。在1月18日週三發佈的一份研究報告中,StockNews.com將Bio-Rad實驗室的股票評級從買入下調至持有。最後,加拿大皇家銀行在12月6日(星期二)的一份研究報告中承擔了對Bio-Rad實驗室股票的報道。他們給出了“跑贏大盤”的評級,並為該公司設定了565.00美元的目標價。一名分析師對該股的評級為持有,四名分析師對該股的評級為買入。根據MarketBeat的數據,Bio-Rad實驗室目前的共識評級為“中等買入”,共識目標價為651.25美元。Bio-Rad實驗室公司簡介
(獲取評級)
Bio-Rad實驗室公司致力於開發和生產用於生化、製藥和其他生命科學研究應用的特殊化學品。它通過生命科學和臨床診斷部門開展業務。生命科學部門開發、製造和銷售試劑、儀器和實驗室儀器。
閱讀更多內容
- 免費獲取StockNews.com關於Bio-Rad實驗室的研究報告(BIO)
- 細價股值得嗎?你應該投資細價股嗎?
- Zimmer Biomet盈利節節攀升,增長可能被計入價格
- 人工智慧軟體製造商EPAM號稱科技板塊漲幅最大
- 福特股票在盈利大幅下滑後繼續前進
- 內部人士和機構收購金剛狼全球
每天收到Bio-Rad實驗室的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Bio-Rad實驗室和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧